A total of 483 patients with HNSCC from the TCGA database were included in the survival analysis and categorized into CD27 high-expression (n = 242) and low-expression (n = 241) groups, with 1.2205156 as the cutoff value. The gene discussed is CD27; the disease is head and neck squamous cell carcinoma.